- Home
- CNMD vs BCRX Comparison
CNMD vs BCRX Comparison
Compare CNMD & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- BCRX
- Stock Information
- Founded
- CNMD 1970
- BCRX 1986
- Country
- CNMD United States
- BCRX United States
- Employees
- CNMD N/A
- BCRX N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNMD Health Care
- BCRX Health Care
- Exchange
- CNMD Nasdaq
- BCRX Nasdaq
- Market Cap
- CNMD 1.7B
- BCRX 1.9B
- IPO Year
- CNMD 1987
- BCRX 1994
- Fundamental
- Price
- CNMD $52.37
- BCRX $9.04
- Analyst Decision
- CNMD Hold
- BCRX Strong Buy
- Analyst Count
- CNMD 5
- BCRX 10
- Target Price
- CNMD $62.20
- BCRX $16.70
- AVG Volume (30 Days)
- CNMD 416.9K
- BCRX 3.4M
- Earning Date
- CNMD 07-30-2025
- BCRX 08-04-2025
- Dividend Yield
- CNMD 1.51%
- BCRX N/A
- EPS Growth
- CNMD 46.38
- BCRX N/A
- EPS
- CNMD 3.81
- BCRX N/A
- Revenue
- CNMD $1,315,998,000.00
- BCRX $503,485,000.00
- Revenue This Year
- CNMD $6.27
- BCRX $39.04
- Revenue Next Year
- CNMD $5.62
- BCRX $13.26
- P/E Ratio
- CNMD $13.86
- BCRX N/A
- Revenue Growth
- CNMD 4.32
- BCRX 41.67
- 52 Week Low
- CNMD $46.00
- BCRX $6.02
- 52 Week High
- CNMD $78.19
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- CNMD 44.12
- BCRX 37.14
- Support Level
- CNMD $51.41
- BCRX $8.71
- Resistance Level
- CNMD $54.21
- BCRX $9.17
- Average True Range (ATR)
- CNMD 1.63
- BCRX 0.32
- MACD
- CNMD 0.08
- BCRX -0.12
- Stochastic Oscillator
- CNMD 42.44
- BCRX 25.00
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.